SARITA GUGLANI: Open Payments
NPI 1609435213 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 17 payments from 9 companies in 2025. Trend: 2023 $315 · 2024 $496 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Eisai Inc. | 1 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
Products named: AIRSUPRA, NURTEC ODT, PREVNAR 20, Leqembi, Kerendia, FARXIGA, ACCRUFER, VRAYLAR.
Industry payments across NC — which companies pay providers there.
